Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Archaeologists uncover details about the Hjortspring boat's origins - 2Extraordinary Shows to Long distance race on a Plane
- 3Live long and loiter: Why NASA's ESCAPADE probes will wait a year in space before heading to Mars
- 46 Useful Home Espresso Machines
- 5Nurturing Hacks: Shrewdness from Experienced Mothers and Fathers
- Mussolini's summer villa on Adriatic coast sold for €1.2 million
- Factbox-Artemis II crew includes first woman, Black astronaut and Canadian ever flown to moon
- Cathay Pacific raises fuel surcharge on all flights by 34%
- New hybrid mpox strain discovered in UK after US reports local spread
- The most effective method to Alter Your Savvy Bed for A definitive Rest Insight
- German finance minister sees advantages of smartphones in schools
- Russian billionaire says 12-hour days and 6-day workweeks could help save the economy
- Figurine of a woman and a goose offers peek at prehistoric beliefs
- A definitive Manual for Picking Electric Vehicle: Decision in favor of Your Number one
